Kyverna Therapeutics, Inc.
USD7.24
-0.21 (-2.82%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.50
Prev. Close
$7.45
Day Low
$7.18
Day High
$7.59
52W Low
$2.80
52W High
$13.67
Market Cap
$0.32B
Volume
1.43M
| 20,582 |
| $8.59 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | Shaw Christi | director, officer: Executive Chairperson | F-InKind | Disposed | 4,194 | $8.59 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 20,582 | $8.59 |
| 20 May 2026 | Martini Gregory S. | Chief Financial Officer | A-Award | Acquired | 325,000 | $8.54 |